Concourse Financial Group Securities, Inc. Lexaria Bioscience Corp. Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LEXX
# of Institutions
24Shares Held
2.48MCall Options Held
0Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ1.17MShares$1.21 Million25.66% of portfolio
-
Invenomic Capital Management LP Boston, MA501KShares$521,5260.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA259KShares$269,1680.0% of portfolio
-
Geode Capital Management, LLC Boston, MA175KShares$181,7700.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6133KShares$138,4500.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $6.19M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...